Artículos por temáticas

Shedding light on microglial dysregulation in Alzheimer's disease: exploring molecular mechanisms and therapeutic avenues

Bhardwaj V, Kumari S, Dhapola R, Sharma P, Beura SK, Singh SK, Vellingiri B, HariKrishnaReddy D.

Inflammopharmacology. 2025 Feb;33(2):679-702. doi: 10.1007/s10787-024-01598-6. Epub 2024 Nov 28.

Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting

Pathak K, Ahmad MZ, Saikia R, Pathak MP, Sahariah JJ, Kalita P, Das A, Islam MA, Pramanik P, Tayeng D, Abdel-Wahab BA.

Cent Nerv Syst Agents Med Chem. 2025;25(1):3-19. doi: 10.2174/0118715249281331240325042642.

Advancements in nose-to-brain drug targeting for Alzheimer's disease: a review of nanocarriers and clinical insights

Komal K, Ghosh R, Sil D, Sharma R, Kumar S, Pandey P, Kumar M.

Inflammopharmacology. 2025 Feb;33(2):605-626. doi: 10.1007/s10787-024-01636-3. Epub 2025 Jan 7.

Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease

Kumari S, Bagri K, Deshmukh R.

Inflammopharmacology. 2025 Feb;33(2):593-603. doi: 10.1007/s10787-024-01638-1. Epub 2025 Jan 14.

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease

Abdelhamid M, Counts SE, Zhou C, Hida H, Kim JI, Michikawa M, Jung CG.

Nutrients. 2025 Jan 31;17(3):558. doi: 10.3390/nu17030558.

Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect

Wang X, Chen L, Li W, He Z, Jiang H.

J Alzheimers Dis. 2025 Jan;103(2):319-332. doi: 10.1177/13872877241304673. Epub 2025 Jan 8.

The Potential Role of Phytochemicals in Alzheimer's Disease

Baranowska-Wójcik E, Gajowniczek-Ałasa D, Pawlikowska-Pawlęga B, Szwajgier D.

Nutrients. 2025 Feb 12;17(4):653. doi: 10.3390/nu17040653.

Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

Chib S, Dutta BJ, Chalotra R, Abubakar M, Kumar P, Singh TG, Singh R.

Phytother Res. 2025 Feb;39(2):747-775. doi: 10.1002/ptr.8406. Epub 2024 Dec 11.

Improvements in Exercise for Alzheimer's Disease: Highlighting FGF21-Induced Cerebrovascular Protection

Wang J, Meng X, Yang J, Tang Y, Zeng F, Wang Y, Chen Z, Chen D, Zou R, Liu W.

Neurochem Res. 2025 Feb 4;50(2):95. doi: 10.1007/s11064-025-04350-w.

Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway

Elhage A, Cohen S, Cummings J, van der Flier WM, Aisen P, Cho M, Bell J, Hampel H.

Alzheimers Dement. 2025 Feb;21(2):e14425. doi: 10.1002/alz.14425. Epub 2024 Dec 19.

The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer's disease

Wang X, Zhang S, Li Y, Zhang Y.

Hum Mol Genet. 2025 Jan 29;34(2):117-127. doi: 10.1093/hmg/ddae154.

Exploring the role of HIF-1α on pathogenesis in Alzheimer's disease and potential therapeutic approaches

Porel P, Bala K, Aran KR.

Inflammopharmacology. 2025 Feb;33(2):669-678. doi: 10.1007/s10787-024-01585-x. Epub 2024 Oct 27.

Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial

Matt E, Mitterwallner M, Radjenovic S, Grigoryeva D, Weber A, Stögmann E, Domitner A, Zettl A, Osou S, Beisteiner R.

JAMA Netw Open. 2025 Feb 3;8(2):e2459170. doi: 10.1001/jamanetworkopen.2024.59170.

Progress in the treatment of Alzheimer's disease based on nanosized traditional Chinese medicines

Song D, Zhang J, Hu X, Liu X.

J Mater Chem B. 2025 Jan 29;13(5):1548-1572. doi: 10.1039/d4tb02062f.

Bifidobacterium infantis and Bifidobacterium breve Improve Symptomatology and Neuronal Damage in Neurodegenerative Disease: A Systematic Review

Reiriz M, Beltrán-Velasco AI, Echeverry-Alzate V, Martínez-Miguel E, Gómez-Senent S, Uceda S, Clemente-Suárez VJ.

Nutrients. 2025 Jan 22;17(3):391. doi: 10.3390/nu17030391.